6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9452159
APP PUB NO 20150238471A1
SERIAL NO

14367237

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method or composition including 6-aminopyridin-3-ol derivatives or pharmaceutically acceptable salts thereof for treating a disease caused by angiogenesis, the 6-aminopyridin-3-ol derivatives represented by Formula 1 or the pharmaceutically acceptable salts thereof have excellent neoangiogenesis inhibition effects in the chorioallantoic membrane model, and are suitable for use as a drug for the treatment of disease caused by angiogenesis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY(DAE-DONG) 280 DAEHAK-RO POHANG-SI 38541

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jeong, Byeong Seon Daegu, KR 8 15
Kang, You Ra Gyeongsan-si, KR 5 10
Kim, Dong Guk Daegu, JP 34 177
Kim, Jung Ae Daegu, JP 27 47
Nam, Tae Gyu Suwon-si, KR 7 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 27, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00